Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 36

1.
2.

Forecasting the future of HIV epidemics: the impact of antiretroviral therapies & imperfect vaccines.

Blower S, Schwartz EJ, Mills J.

AIDS Rev. 2003 Apr-Jun;5(2):113-25. Review.

PMID:
12876900
3.

What can modeling tell us about the threat of antiviral drug resistance?

Blower S, Volberding P.

Curr Opin Infect Dis. 2002 Dec;15(6):609-14. Review.

PMID:
12821838
4.

Tuberculosis vaccines.

Young DB, Stewart GR.

Br Med Bull. 2002;62:73-86. Review.

PMID:
12176851
5.

What's new in tuberculosis vaccines?

Ginsberg AM.

Bull World Health Organ. 2002;80(6):483-8.

6.

BCG--different strains, different vaccines?

Behr MA.

Lancet Infect Dis. 2002 Feb;2(2):86-92. Review.

PMID:
11901655
7.

Amplification dynamics: predicting the effect of HIV on tuberculosis outbreaks.

Porco TC, Small PM, Blower SM.

J Acquir Immune Defic Syndr. 2001 Dec 15;28(5):437-44.

PMID:
11744831
8.

New TB vaccines to be tested.

Thomson J.

Nat Med. 2001 Dec;7(12):1263. No abstract available.

PMID:
11726944
9.

Modeling the economic benefits of better TB vaccines.

Bishai DM, Mercer D.

Int J Tuberc Lung Dis. 2001 Nov;5(11):984-93.

PMID:
11716349
10.

Predicting the unpredictable: transmission of drug-resistant HIV.

Blower SM, Aschenbach AN, Gershengorn HB, Kahn JO.

Nat Med. 2001 Sep;7(9):1016-20. Erratum in: Nat Med. 2003 Jan;9(1):146..

PMID:
11533704
11.

Strategies to decrease tuberculosis in us homeless populations: a computer simulation model.

Brewer TF, Heymann SJ, Krumplitsch SM, Wilson ME, Colditz GA, Fineberg HV.

JAMA. 2001 Aug 15;286(7):834-42.

PMID:
11497538
12.

Protection of mice with a tuberculosis subunit vaccine based on a fusion protein of antigen 85b and esat-6.

Weinrich Olsen A, van Pinxteren LA, Meng Okkels L, Birk Rasmussen P, Andersen P.

Infect Immun. 2001 May;69(5):2773-8.

13.

Live attenuated HIV vaccines: predicting the tradeoff between efficacy and safety.

Blower SM, Koelle K, Kirschner DE, Mills J.

Proc Natl Acad Sci U S A. 2001 Mar 13;98(6):3618-23.

14.

Early therapy for latent tuberculosis infection.

Ziv E, Daley CL, Blower SM.

Am J Epidemiol. 2001 Feb 15;153(4):381-5.

PMID:
11207156
15.

Prospects for vaccines to protect against AIDS, tuberculosis, and malaria.

Letvin NL, Bloom BR, Hoffman SL.

JAMA. 2001 Feb 7;285(5):606-11.

PMID:
11176867
17.

Potential impact of tuberculosis vaccines as epidemic control agents.

Lietman T, Blower SM.

Clin Infect Dis. 2000 Jun;30 Suppl 3:S316-22. Review.

PMID:
10875909
18.

A proposed national strategy for tuberculosis vaccine development.

Ginsberg AM.

Clin Infect Dis. 2000 Jun;30 Suppl 3:S233-42.

PMID:
10875790
19.

A tale of two futures: HIV and antiretroviral therapy in San Francisco.

Blower SM, Gershengorn HB, Grant RM.

Science. 2000 Jan 28;287(5453):650-4.

20.

Tuberculosis vaccines.

Lietman T, Blower S.

Science. 1999 Nov 12;286(5443):1300-1; author reply 1301. No abstract available.

PMID:
10610535

Supplemental Content

Support Center